Molecular Analysis for Lung Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate the effectiveness of robotic biopsies in identifying genetic markers that may aid in diagnosing lung cancer. Researchers will collect blood or saliva samples, review medical records, and analyze any genetic variants found. The trial is suitable for individuals at moderate to high risk of lung cancer who are scheduled or were scheduled for a bronchoscopy. Participants must also provide a tissue sample from a past procedure.
As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, allowing participants to contribute to significant advancements in lung cancer diagnosis.
Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to personalize lung cancer care through a more precise genetic approach. Unlike standard treatments that typically focus on generalized protocols like chemotherapy or radiation, this trial uses genomic counseling and testing to identify unique genetic variants in patients. By analyzing these specific genetic markers, the trial hopes to tailor treatments that better target the cancer's individual characteristics, potentially leading to more effective and personalized care options.
Who Is on the Research Team?
Janani S. Reisenauer, M.D.
Principal Investigator
Mayo Clinic in Rochester
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Genomic Counseling and Testing
Participants receive genomic counseling and genomic testing education, undergo blood or saliva collection, provide previously collected tissue sample, and have medical records reviewed.
Follow-up
Participants are monitored for the adequacy of samples for sequencing and the development of a genomic data bank.
What Are the Treatments Tested in This Trial?
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Patients receive genomic counseling and genomic testing education, undergo blood or saliva collection, provide previously collected tissue sample and have medical records reviewed on study. Patients and healthcare providers receive results of any genetic variants found on testing.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.